Abstract
Globally, there are over one billion people infected with soil-transmitted helminths (STHs), mostly living in marginalised settings with inadequate sanitation in sub-Saharan Africa and Southeast Asia. The WHO recommends an integrated approach to STH morbidity control through improved access to sanitation and hygiene education, and the delivery of preventive chemotherapy (PC) to school age children delivered through schools. Progress of STH control programmes is currently estimated using a baseline (pre-PC) school-based prevalence survey and then monitored using periodical school-based prevalence surveys, known as Impact Assessment Surveys (IAS). We investigated whether integrating geostatistical methods with a Markov model or a mechanistic transmission model for projecting prevalence forward in time from baseline can improve IAS design strategies. To do this, we applied these two methods to prevalence data collected in Kenya, before evaluating and comparing their performance in accurately informing optimal survey design for a range of IAS sampling designs. We found that although both approaches performed well, the mechanistic method more accurately projected prevalence over time and provided more accurate information for guiding survey design. Both methods performed less well in areas with persistent STH hotspots where prevalence did not reduce despite multiple rounds of PC. Our findings show that these methods can be useful tools for more efficient and accurate targeting of PC. The general framework built in this paper can also be used for projecting prevalence and informing survey design for other NTDs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this project was provided by the Bill and Melinda Gates Foundation via grant INV-030046 to the NTD Modelling Consortium: informing program decision-making.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used openly available human data that are publicly available via the Global Atlas of Helminth Infections (https://www.thiswormyworld.org/) and the ESPEN portal (https://espen.afro.who.int/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All human data used in this analysis are publicly available via the Global Atlas of Helminth Infections (https://www.thiswormyworld.org/) and the ESPEN portal (https://espen.afro.who.int/). All environmental data used are publicly available from MODIS and WorldPop.
